| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |